➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
Merck
Express Scripts
Baxter

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Pharm Res Assoc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PHARM RES ASSOC, and what generic and branded alternatives to PHARM RES ASSOC drugs are available?

PHARM RES ASSOC has eight approved drugs.



Summary for Pharm Res Assoc
US Patents:0
Tradenames:9
Ingredients:9
NDAs:8

Drugs and US Patents for Pharm Res Assoc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc PHENY-PAS-TEBAMIN phenyl aminosalicylate TABLET;ORAL 011695-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc CARDIOQUIN quinidine polygalacturonate TABLET;ORAL 011642-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc SULFABID sulfaphenazole SUSPENSION;ORAL 013093-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-007 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-005 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc ATHROMBIN warfarin sodium TABLET;ORAL 011771-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Pharm Res Assoc DHC PLUS acetaminophen; caffeine; dihydrocodeine bitartrate CAPSULE;ORAL 088584-001 Mar 4, 1986 DISCN No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
Colorcon
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.